Speeding and Scaling the Development of Genome Editing Therapies

Fyodor Urnov, director of technology and translation for the Innovative Genomics Institute and director of the new Danaher-IGI Beacon for CRISPR Cures center, discusses the evolution of gene editing technology, the challenges of a platform approach to gene editing, and how the organization plans to share what it learns.